MX9204905A - Acidos aminometanodifosfonicos n-substituidos y procedimiento para su obtencion - Google Patents

Acidos aminometanodifosfonicos n-substituidos y procedimiento para su obtencion

Info

Publication number
MX9204905A
MX9204905A MX9204905A MX9204905A MX9204905A MX 9204905 A MX9204905 A MX 9204905A MX 9204905 A MX9204905 A MX 9204905A MX 9204905 A MX9204905 A MX 9204905A MX 9204905 A MX9204905 A MX 9204905A
Authority
MX
Mexico
Prior art keywords
acids
substituted
aminomethaniphyphosphonic
procedure
obtaining
Prior art date
Application number
MX9204905A
Other languages
English (en)
Inventor
Knut Alfred Jaeggi
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of MX9204905A publication Critical patent/MX9204905A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3873Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Dental Preparations (AREA)
MX9204905A 1991-08-27 1992-08-25 Acidos aminometanodifosfonicos n-substituidos y procedimiento para su obtencion MX9204905A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91810682 1991-08-27

Publications (1)

Publication Number Publication Date
MX9204905A true MX9204905A (es) 1993-04-01

Family

ID=8208873

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9204905A MX9204905A (es) 1991-08-27 1992-08-25 Acidos aminometanodifosfonicos n-substituidos y procedimiento para su obtencion

Country Status (19)

Country Link
US (1) US5281748A (es)
EP (1) EP0531253B1 (es)
JP (1) JPH05222074A (es)
KR (1) KR930004317A (es)
AT (1) ATE147396T1 (es)
AU (1) AU657983B2 (es)
CA (1) CA2076801A1 (es)
DE (1) DE69216514T2 (es)
DK (1) DK0531253T3 (es)
ES (1) ES2096061T3 (es)
FI (1) FI923797A (es)
GR (1) GR3022243T3 (es)
HU (1) HUT62303A (es)
IL (1) IL102959A (es)
MX (1) MX9204905A (es)
NO (1) NO923331L (es)
NZ (1) NZ244078A (es)
TW (1) TW207543B (es)
ZA (1) ZA926434B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0541037A3 (en) * 1991-11-06 1997-02-26 Takeda Chemical Industries Ltd Squalene synthetase inhibitory composition and use thereof
TW258729B (es) * 1992-06-22 1995-10-01 Ciba Geigy
DE4223940A1 (de) * 1992-07-21 1994-01-27 Boehringer Mannheim Gmbh Neue acyclische Amidingruppen-haltige Diphosphonsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
GB9300641D0 (en) * 1993-01-14 1993-03-03 Zeneca Ltd Process
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
IT1303672B1 (it) 1998-07-28 2001-02-23 Nicox Sa Sali nitrati di farmaci attivi nei disordini ossei

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2316396C3 (de) * 1973-04-02 1975-09-18 Joh. A. Benckiser Gmbh, 6700 Ludwigshafen N(1,1-Di-phosphono-äthyl)acetamidin, seine Herste lung und Verwendung zur Steinverhütung
DE3208600A1 (de) * 1982-03-10 1983-09-22 Henkel KGaA, 4000 Düsseldorf Amidinodiphosphonsaeuren
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4963681A (en) * 1987-07-06 1990-10-16 Norwich Eaton Pharmaceuticals, Inc. Process for synthesis of aminomethylene phosphonoalkylphosphinates
PH26923A (en) * 1989-03-08 1992-12-03 Ciba Geigy N-substituted amino alkanediphosphonic acids
IE912115A1 (en) * 1990-06-25 1992-01-01 Takeda Chemical Industries Ltd Bisphosphonic acid derivatives, their production and use
US5043099A (en) * 1990-07-13 1991-08-27 Kreh Robert P Mono- and di-substituted (diphosphonoalkylamino methyl)-4-hydroxybenzenesulfonic acid
DE69116838T2 (de) * 1990-12-19 1996-06-13 Takeda Chemical Industries Ltd Bisphosphonsäurederivate, ihre Produktion und ihre Verwendung

Also Published As

Publication number Publication date
EP0531253B1 (en) 1997-01-08
FI923797A0 (fi) 1992-08-24
CA2076801A1 (en) 1993-02-28
EP0531253A1 (en) 1993-03-10
ZA926434B (en) 1993-04-28
FI923797A (fi) 1993-02-28
GR3022243T3 (en) 1997-04-30
NZ244078A (en) 1994-12-22
AU2128892A (en) 1993-03-04
DK0531253T3 (da) 1997-01-27
JPH05222074A (ja) 1993-08-31
HU9202754D0 (en) 1992-12-28
KR930004317A (ko) 1993-03-22
DE69216514T2 (de) 1997-07-31
AU657983B2 (en) 1995-03-30
NO923331D0 (no) 1992-08-26
ES2096061T3 (es) 1997-03-01
ATE147396T1 (de) 1997-01-15
DE69216514D1 (de) 1997-02-20
US5281748A (en) 1994-01-25
TW207543B (es) 1993-06-11
IL102959A0 (en) 1993-01-31
IL102959A (en) 1998-01-04
HUT62303A (en) 1993-04-28
NO923331L (no) 1993-03-01

Similar Documents

Publication Publication Date Title
NO940038D0 (no) Arylsulfonamido-substituerte hydrokamsyrer
NO941052D0 (no) Benzimidazolforbindelser, deres anvendelse og fremstilling
MA22014A1 (fr) Derives d'acides amines .
CY1110745T1 (el) Παραγωγα πυρρολιδονης ως αναστολεις μαοβ
NO924915D0 (no) Sakkarinderivater med inhiberende virkning paa protolytiske enzymer
DE68914292D1 (de) Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
DE68923151D1 (de) Verwendung von Trifluormethylphenyl-Tetrahydropyridinen zur Herstellung von Arzneimitteln zur Behandlung anxio-depressiver Erkrankungen.
MX9204905A (es) Acidos aminometanodifosfonicos n-substituidos y procedimiento para su obtencion
ES2039267T3 (es) Dihidropiridinamidas, procedimiento para su preparacion y su empleo en medicamentos.
DK0610078T3 (da) Cytotoksisk og antiviral forbindelse.
NO170881C (no) Salicylsyreamider og deres anvendelse, i kosmetiske sammensetninger
ATE137759T1 (de) S'-adenosyl-methionin-decarboxylase-inhibitoren
DE3880304D1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central
DK730488A (da) Synergistisk kombination af decarboxylasehaemmere og l-dopa-pellets
FI812773L (fi) Foerfarande foer framstaellning av n-/4-/(2,4-diamino-6-pteridinyl)-metyl/metylamino/benzoyl/glutaminsyra
FR2583756B1 (fr) Procede de preparation des derives de la 2-halo-nicergoline et leurs sels d'addition avec des acides ainsi que des 2-halonicergolines nouvelles, compositions comportant des 2-halonicergolines et procede de preparation
SE8005309L (sv) Nya 5alfa-pregnan-20-ol-derivat och salter derav med syror, sett for framstellning samt anvendning derav sasom lekemedel samt kompositioner innehallande dessa foreningar
ES2086395T3 (es) Fosfolipidos para el tratamiento de esclerosis multiple.